AWARD. This year, Copenhagen University Hospital – Rigshospitalet’s International KFJ Award goes to Swedish Professor Kaj Blennow, who is recognized as a global leader in the development of biomarkers for the diagnosis of Alzheimer’s disease. The use of biomarkers in clinical practice and research is rapidly advancing in healthcare. In the field of neurodegenerative diseases, such as Alzheimer’s disease, Swedish Professor Kaj Blennow is one of the forefront figures in…
85 percent voted yes to Jenny Nyström as the new dean
DEAN ELECTION. Jenny Nyström received just over 85 percent of the votes in the dean election, where voter turnout reached almost 50 percent. At the same time, Sahlgrenska Academy’s drafting committee is also presenting its candidate for pro dean: Magnus Simrén, professor of medical gastroenterology at the Institute of Medicine. In January 2023, the faculty-wide drafting committee was tasked by the faculty board to, in consultation with the Vice-Chancellor, initiate…
Obesity particularly hard on people with bipolar disorders
NEW STUDY. The obesity pandemic is particularly hard on people with bipolar disorders. This has been shown in a study conducted at the University of Gothenburg. The results suggest that the group of adults with bipolar disorders will fall behind in life expectancy compared with the general population. It is already known that adults with bipolar disorders are also more prone to obesity. The current study, published in the American…
The pandemic a tough time also for pharmacies
NEW STUDY. Customers showing up even when they were sick, not agreeing with the restrictions, and many new tasks for staff. These are factors that contributed to heavier workloads and tougher work environments in pharmacies during the pandemic, a study reveals. The scientific study, published in the journal Exploratory Research in Clinical and Social Pharmacy, was conducted by researchers at the University of Gothenburg and Åbo Akademi University. The data…
New blood test gives very high accuracy to screen for Alzheimer’s disease
NEW STUDY. A new blood test called p-tau217 shows promise as an Alzheimer’s disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest pathology. That is an innovation now presented by researchers at the University of Gothenburg, together with colleagues at University of Lund and in Montreal, Canada. In recent years, a lot of effort has…